Spots Global Cancer Trial Database for core biopsy
Every month we try and update this database with for core biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma | NCT03880019 | Stage III Uteri... Stage IV Uterin... Uterine Corpus ... | Computed Tomogr... Core Biopsy Magnetic Resona... Olaparib Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT05688215 | Borderline Rese... Locally Advance... | Biospecimen Col... Computed Tomogr... Core Biopsy Fluorouracil Irinotecan Leucovorin Leucovorin Calc... Oxaliplatin Quemliclustat Zimberelimab | 18 Years - | Jonsson Comprehensive Cancer Center | |
Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules | NCT04759053 | Thyroid Nodule Thyroid Disease... Thyroid Gland; ... | FNB Core biopsy | 18 Years - 65 Years | Kafrelsheikh University | |
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas | NCT05053971 | Advanced Lympho... Advanced Malign... Advanced Pancre... B-Cell Non-Hodg... Metastatic Panc... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | BET Bromodomain... Core Biopsy Entinostat | 18 Years - | National Cancer Institute (NCI) | |
Breast Cancer Molecular Analysis Protocol | NCT01855503 | Metastatic Brea... | Core Biopsy | - | Yale University | |
Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery | NCT02455791 | Breast Cancer | Ultrasound-Guid... | 18 Years - | M.D. Anderson Cancer Center | |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast | NCT04009044 | Cancer Survivor Ductal Breast C... Invasive Breast... | Afimoxifene Core Biopsy Questionnaire A... | 18 Years - | Northwestern University | |
Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus | NCT01300429 | Lung Cancer | obtain tissue s... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | NCT03418038 | Clonal Cytopeni... High Grade B-Ce... Recurrent Diffu... Recurrent Hodgk... Recurrent Lymph... Refractory Diff... Refractory Lymp... Chronic Myelomo... | Ascorbic Acid Carboplatin Cisplatin Cytarabine Dexamethasone Etoposide Gemcitabine Hyd... Ifosfamide Laboratory Biom... Oxaliplatin Placebo Adminis... Questionnaire A... Rituximab Decitabine Biospecimen Col... Core Biopsy Bone Marrow Asp... Bone Marrow Bio... Echocardiograph... Positron Emissi... Magnetic Resona... Central Venous ... Portacath Place... Computed Tomogr... | 18 Years - | Mayo Clinic | |
Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle | NCT02181140 | Pancreatic Neop... | EUS guided FNA ... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast | NCT04009044 | Cancer Survivor Ductal Breast C... Invasive Breast... | Afimoxifene Core Biopsy Questionnaire A... | 18 Years - | Northwestern University | |
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer | NCT00537173 | Breast Cancer | Core Biopsy Blood Collectio... Paclitaxel Avastin | 18 Years - | Hoosier Cancer Research Network | |
Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle | NCT02181140 | Pancreatic Neop... | EUS guided FNA ... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
False/Negative Rate of Lung Percutaneous Needle Biopsy | NCT00638352 | Lung Neoplasm | 18 Years - | State University of New York - Upstate Medical University | ||
Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus | NCT01300429 | Lung Cancer | obtain tissue s... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | NCT03418038 | Clonal Cytopeni... High Grade B-Ce... Recurrent Diffu... Recurrent Hodgk... Recurrent Lymph... Refractory Diff... Refractory Lymp... Chronic Myelomo... | Ascorbic Acid Carboplatin Cisplatin Cytarabine Dexamethasone Etoposide Gemcitabine Hyd... Ifosfamide Laboratory Biom... Oxaliplatin Placebo Adminis... Questionnaire A... Rituximab Decitabine Biospecimen Col... Core Biopsy Bone Marrow Asp... Bone Marrow Bio... Echocardiograph... Positron Emissi... Magnetic Resona... Central Venous ... Portacath Place... Computed Tomogr... | 18 Years - | Mayo Clinic | |
EchoTip AcuCore Post-Market Clinical Study | NCT06358001 | Adenocarcinoma Neuroendocrine ... Hepatocellular ... Cholangiocarcin... Malignant Lymph... Metastasis Chronic Pancrea... Autoimmune Panc... | EchoTip AcuCore | 18 Years - | Cook Group Incorporated | |
EchoTip AcuCore Post-Market Clinical Study | NCT06358001 | Adenocarcinoma Neuroendocrine ... Hepatocellular ... Cholangiocarcin... Malignant Lymph... Metastasis Chronic Pancrea... Autoimmune Panc... | EchoTip AcuCore | 18 Years - | Cook Group Incorporated | |
Breast Cancer Molecular Analysis Protocol | NCT01855503 | Metastatic Brea... | Core Biopsy | - | Yale University |